Latest Biotechnology, Pharmaceutical and Healthcare News from PMLIVE

09:56 EDT 19th April 2018 | BioPortfolio

Here are the most relevant search results for "PMLIVE" found in our extensive news archives from over 250 global news sources.

More Information about PMLIVE on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PMLIVE for you to read. Along with our medical data and news we also list PMLIVE Clinical Trials, which are updated daily. BioPortfolio also has a large database of PMLIVE Companies for you to search.

Showing News Articles 1–25 of 989 from PMLIVE

Thursday 19th April 2018

P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit

Will also access Merck’s big-selling Neurobion and the Nasivin nasal decongestant range

Publicis LifeBrands Team win UK young Cannes Lions competition

Tom Wordley and Jon Webb will represent the UK at the competition

Sobi poaches Pfizer’s Fredrick Wetterlundh

He joins the speciality healthcare group as head of human resources

Rigel and Ultragenyx claim approvals for rare drugs

Tavalisse and Crysvita are set to treat patients with chronic ITP and XLH, respectively

Wednesday 18th April 2018

The threat of antimicrobial resistance

Why this issue is such a fundamental challenge

Good Relations win Nuffield Health account

The agency will combine Nuffield Health’s gym and hospital offerings

Amgen and Novartis migraine drug hits the mark again

Aimovig will become the first CGRP receptor-targeting drug if it reaches market

Sanofi sells European generics to Advent for $2.4bn

The deal will create a new, independent European generics company

Smith & Nephew name new CEO

Namal Nawana will also become an executive director

Targovax strengthens board of directors

Catherine Wheeler joins from Acetylon Pharmaceutical

Tuesday 17th April 2018

BMS claims rapid FDA nod for Opdivo plus Yervoy in kidney cancer

Data shows the combo can improve survival compared to Pfizer’s Sutent

Merck’s Keytruda meets survival challenge in NSCLC

Data showed that almost 70% of patients on the combo were still alive after 12 months

emotive bolsters client services team

Natalie Lilienthal joins the agency as senior account director

Dermavant strengthens executive team

David Rubenstein, Richard Peterson, Ariel Jasie and Chris Van Tuyl join the group

Monday 16th April 2018

Brexit Means Brexit

The differential destinations of post-Brexit pharma

The Creative Floor launch portfolio and jobs site

The site will be exclusive to advertising creatives

AZ makes case for first-line Tagrisso therapy in lung cancer

Data shows the drug improved PFS versus older EGFR inhibitors including Roche’s Tarceva

Shire offloads oncology unit to Servier for $2.4bn

The French drugmaker will also acquire Oncaspar and Onivyde as part of the deal

Sunday 15th April 2018

What makes a meaningful brand?

Friday 13th April 2018

Sanofi backs vaccines unit with €350m Canadian facility

The new plant will make paediatric and booster vaccines

Artificial intelligence in healthcare ‘set for 40% growth to 2024’

And the US, the UK and China are all expected to be front-runners

Neurocentrx appoints two members to the board

Nigel Brooksby and Dr Tim Corn join the pharma group

Open Access Consulting appoints new director

Jayne Hurrell joins the group from Evidera

Thursday 12th April 2018

Beyond caring: learning from the unsung advocates in cancer care

Editas Medicine names James Mullen as chairman

He has previously served as CEO of Patheon

Quick Search


News Quicklinks